Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer
Year: 2017
Type: article
Source: Gynecologic Oncology
Authors: M.A. Geller, L.A. Bendzick, C. Ryan, S. Chu, A. Lenvik, A.P.N. Skubitz, K.L.M. Boylan, R. Isaksson Vogel, J. Miller, M. Felices
Institutions: University of Minnesota, Masonic Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2623870901
